A detailed history of White Pine Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, White Pine Capital LLC holds 18,040 shares of BMY stock, worth $1.01 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
18,040
Previous 20,663 12.69%
Holding current value
$1.01 Million
Previous $858,000 8.74%
% of portfolio
0.33%
Previous 0.33%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $104,028 - $135,740
-2,623 Reduced 12.69%
18,040 $933,000
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $104,891 - $138,091
-2,606 Reduced 11.2%
20,663 $858,000
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $3,646 - $4,134
-76 Reduced 0.33%
23,269 $1.26 Million
Q4 2023

Feb 02, 2024

SELL
$48.48 - $57.85 $306,490 - $365,727
-6,322 Reduced 21.31%
23,345 $1.2 Million
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $16,498 - $18,448
-285 Reduced 0.95%
29,667 $1.72 Million
Q2 2023

Aug 08, 2023

SELL
$63.71 - $70.74 $21,279 - $23,627
-334 Reduced 1.1%
29,952 $1.92 Million
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $14,456 - $16,396
-220 Reduced 0.72%
30,286 $2.1 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $36,225 - $42,896
529 Added 1.76%
30,506 $2.19 Million
Q3 2022

Nov 08, 2022

BUY
$0.13 - $76.84 $39 - $23,359
304 Added 1.02%
29,977 $2.13 Million
Q2 2022

Aug 16, 2022

BUY
$72.62 - $79.98 $12,490 - $13,756
172 Added 0.58%
29,673 $2.29 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $216,962 - $260,157
3,529 Added 13.59%
29,501 $2.15 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $193,604 - $225,697
3,610 Added 16.14%
25,972 $1.62 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $472,992 - $515,088
7,640 Added 51.9%
22,362 $1.52 Million
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $1,483 - $1,668
-25 Reduced 0.17%
14,722 $929,000
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $1,385 - $1,570
24 Added 0.16%
14,747 $915,000
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $1,148 - $1,272
-20 Reduced 0.14%
14,723 $888,000
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $7,470 - $10,856
-161 Reduced 1.08%
14,743 $822,000
Q4 2019

Feb 12, 2020

SELL
$49.21 - $64.19 $133,457 - $174,083
-2,712 Reduced 15.4%
14,904 $957,000
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $40,289 - $47,768
-942 Reduced 5.08%
17,616 $893,000
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $441,291 - $487,972
-9,890 Reduced 34.77%
18,558 $842,000
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $115,552 - $137,781
-2,561 Reduced 8.26%
28,448 $1.36 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $11,117 - $14,416
-228 Reduced 0.73%
31,009 $1.61 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $3,863 - $4,357
-70 Reduced 0.22%
31,237 $1.94 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $36,634 - $45,660
-725 Reduced 2.26%
31,307 $1.73 Million
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $647,495 - $745,397
-10,806 Reduced 25.23%
32,032 $2.03 Million
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $68,451 - $74,629
1,142 Added 2.74%
42,838 $2.63 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $2.3 Million - $2.66 Million
41,696
41,696 $2.66 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track White Pine Capital LLC Portfolio

Follow White Pine Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of White Pine Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on White Pine Capital LLC with notifications on news.